Clinical Trial Detail

NCT ID NCT03122509
Title A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

colorectal cancer

Therapies

Durvalumab + Tremelimumab

Age Groups: adult senior

No variant requirements are available.